Risks, Side Effects, and Medication Considerations Bremelanotide is safe and regulated, but just like any drug, it has side effects and risks
Surprisingly, in patients with thyroid disorders we observed increased PAI-1 levels, without any changes in its activity
In the phase 2 randomised controlled trial (Jastreboff et al., New England Journal of Medicine , 2023), participants receiving higher doses of retatrutide achieved mean weight reductions of up to 17.5% of body weight over 24 weeks, with greater losses reported at 48 weeks
The extended half-life results from changes that increase the peptides shelf life and possibly let albumin binding similar to semaglutides mechanism
Ekstrom can recommend the approach that best aligns with each patients desired outcome